The KLHL3 gene plays a crucial role in the regulation of blood pressure and electrolyte balance within the body. Mutations in this gene are associated with Pseudohypoaldosteronism Type 2D (PHA2D), a rare genetic disorder that affects the kidney's ability to properly manage potassium, sodium, and chloride levels. This imbalance leads to high blood pressure (hypertension) and elevated blood potassium levels (hyperkalemia), which can have significant health implications if not diagnosed and managed appropriately.
To diagnose this condition, a genetic test targeting the KLHL3 gene can be conducted. This test is designed to identify specific mutations in the KLHL3 gene that are known to cause PHA2D, providing crucial information for accurate diagnosis and management of the condition. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability.
The cost of the KLHL3 Gene Pseudohypoaldosteronism Type 2D Genetic Test at DNA Labs UAE is 4400 AED. This cost covers the genetic analysis and the provision of a detailed report that can help healthcare providers develop an effective treatment plan tailored to the patient's specific genetic makeup. Given the complexity of genetic testing and the specialized expertise required, the test is an investment in accurate diagnosis and personalized care for patients suspected of having PHA2D.
The CUL3 Gene Pseudohypoaldosteronism Type 2E Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the CUL3 gene, which are associated with Pseudohypoaldosteronism Type 2E (PHA2E). This condition is a rare form of hypertension characterized by an abnormal increase in blood potassium levels, acidosis, and high blood pressure. The test plays a crucial role in the early detection and management of PHA2E, enabling healthcare providers to tailor treatment plans to manage symptoms effectively and improve patient outcomes.
Performed at DNA Labs UAE, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the CUL3 gene. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results. Given the complexity of genetic conditions like PHA2E, obtaining a precise diagnosis through such genetic testing is invaluable for affected individuals and their families, offering insights into the condition and guiding decisions regarding care and management.
The BMPR2 Gene Pulmonary Hypertension Primary Type Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the BMPR2 gene, which are strongly associated with hereditary pulmonary arterial hypertension (PAH). This condition is characterized by high blood pressure in the arteries of the lungs, leading to heart failure if left untreated. The BMPR2 gene plays a crucial role in the development and function of blood vessels, and mutations in this gene can significantly increase an individual's risk of developing PAH.
This test is particularly important for individuals with a family history of pulmonary hypertension, as it can provide vital information for early diagnosis and management of the condition. By identifying specific genetic mutations, healthcare providers can tailor treatment plans to manage symptoms effectively and potentially improve outcomes for patients with hereditary PAH.
The BMPR2 Gene Pulmonary Hypertension Primary Type Genetic Test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. DNA Labs UAE utilizes state-of-the-art technology to ensure reliable and precise genetic testing, offering individuals and families critical insights into their genetic health and helping to guide clinical decision-making.
The BMPR2 Gene Pulmonary Venoocclusive Disease Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the BMPR2 gene that are associated with Pulmonary Venoocclusive Disease Type 1 (PVOD1). PVOD1 is a rare form of pulmonary hypertension characterized by the obstruction of small veins in the lungs, leading to increased blood pressure in the pulmonary arteries. This condition can result in significant health issues, including heart failure, and requires early and accurate diagnosis for effective management.
The test analyzes the BMPR2 gene, which plays a crucial role in the regulation of blood vessel formation and is known to be mutated in a significant proportion of PVOD1 cases. By identifying mutations in this gene, the test can confirm a diagnosis of PVOD1, enabling healthcare providers to tailor treatment strategies to the specific genetic makeup of the patient.
Offered at a cost of 4400 AED, the BMPR2 Gene Pulmonary Venoocclusive Disease Type 1 Genetic Test at DNA Labs UAE represents a critical tool in the diagnosis and management of this rare but serious condition. The test is performed using a sample of the patient's blood or saliva, making it a minimally invasive procedure. With the support of DNA Labs UAE's advanced genetic testing capabilities, patients and their families can gain valuable insights into the genetic basis of PVOD1, facilitating informed decisions about care and treatment.
The ADA2 Gene Sneddon Syndrome Genetic Test is a sophisticated diagnostic tool designed to detect mutations in the ADA2 gene, which are associated with Sneddon Syndrome. Sneddon Syndrome is a rare, progressive disorder characterized by the combination of cerebrovascular disease with livedo reticularis (a mottled discoloration of the skin). This condition can lead to a range of symptoms from skin abnormalities to more severe complications such as strokes or other neurological issues.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic variations linked to this condition. Through a blood sample, the test looks for specific mutations in the ADA2 gene that have been implicated in Sneddon Syndrome. Identifying these mutations can be crucial for the diagnosis, management, and understanding of the disease progression in affected individuals. It also provides valuable information for family planning and the assessment of risk in family members.
The GP1BA Gene Bernard Soulier Syndrome Type A2 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the GP1BA gene, which are responsible for Bernard-Soulier Syndrome (BSS) Type A2. Bernard-Soulier Syndrome is a rare inherited bleeding disorder characterized by the deficiency or dysfunction of the platelet glycoprotein complex GPIb-IX-V, leading to prolonged bleeding times, thrombocytopenia, and unusually large platelets. Type A2 specifically involves mutations in the GP1BA gene, affecting the production or function of the GPIb alpha chain, a critical component of the platelet glycoprotein complex necessary for normal platelet adhesion and clot formation.
This genetic test is performed at DNA Labs UAE, a facility known for its advanced diagnostic services and precision medicine. The test involves collecting a blood sample from the patient, which is then analyzed using state-of-the-art genetic sequencing technologies to identify any mutations in the GP1BA gene. The outcome of this test is crucial for the accurate diagnosis of BSS Type A2, enabling healthcare providers to tailor treatment plans according to the specific needs of the patient, which may include platelet transfusions, antifibrinolytic medications, or recombinant factor VIIa for bleeding management.
The cost of the GP1BA Gene Bernard Soulier Syndrome Type A2 Genetic Test at DNA Labs UAE is 4400 AED. This cost reflects the comprehensive nature of the test, including the advanced genetic sequencing required to identify the specific gene mutations responsible for the condition. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of their condition, facilitating informed decisions regarding treatment and management strategies.
The GP1BB Gene Bernard Soulier Syndrome Type B Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the GP1BB gene. This gene plays a crucial role in the proper functioning of platelets, which are essential for blood clotting. Mutations in the GP1BB gene can lead to Bernard-Soulier Syndrome Type B, a rare inherited bleeding disorder characterized by abnormally large platelets, a reduced number of platelets, and prolonged bleeding times.
This genetic test involves collecting a DNA sample, typically through a blood draw, and examining the GP1BB gene for specific mutations associated with the syndrome. The process is critical for individuals with a family history of the condition or those exhibiting symptoms suggestive of Bernard-Soulier Syndrome, such as easy bruising, frequent nosebleeds, or excessive bleeding from minor wounds.
At DNA Labs UAE, the GP1BB Gene Bernard Soulier Syndrome Type B Genetic Test is offered at a cost of 4400 AED. The test is conducted in a state-of-the-art laboratory setting by experienced geneticists and laboratory technicians. Results from this test can provide essential information for diagnosis, allowing for appropriate management and treatment strategies to be implemented, and can also offer valuable insights for family planning purposes.
Given the implications of the results, genetic counseling is often recommended alongside the test to help individuals and families understand the potential outcomes and to provide support in making informed decisions about their health and future.
The GP9 Gene Bernard Soulier Syndrome Type C Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GP9 gene associated with Bernard-Soulier Syndrome Type C. This condition is a rare inherited bleeding disorder characterized by the deficiency or malfunction of platelets, leading to prolonged bleeding times. The GP9 gene plays a critical role in the proper formation and function of platelets. Mutations in this gene can disrupt platelet function, resulting in the symptoms associated with Bernard-Soulier Syndrome.
The test is conducted through a blood sample, where DNA is extracted and analyzed for specific genetic alterations in the GP9 gene. This precise genetic testing helps in confirming the diagnosis, allowing for appropriate management and treatment plans tailored to the patient's specific condition. Furthermore, it can provide valuable information for family planning and genetic counseling for affected families.
The cost of the GP9 Gene Bernard Soulier Syndrome Type C Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its potential implications for patient care, it represents a crucial investment for individuals exhibiting symptoms suggestive of Bernard-Soulier Syndrome or those with a family history of the condition. Early and accurate diagnosis can significantly impact the quality of life for individuals with this syndrome, enabling better management of symptoms and reducing the risk of complications associated with excessive bleeding.
The NOTCH3 Gene CADASIL Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the NOTCH3 gene, which are strongly associated with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). CADASIL is a rare genetic disorder that affects the small blood vessels in the brain, leading to a range of symptoms such as migraines, mood disturbances, recurrent strokes, and cognitive decline. Early detection through genetic testing is crucial for managing symptoms and planning preventive care.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability. The cost of the NOTCH3 Gene CADASIL Genetic Test is set at 4400 AED. This investment in health allows individuals with a family history of CADASIL or those exhibiting symptoms to gain valuable insights into their genetic predisposition, enabling them to make informed decisions regarding their health and lifestyle.
The RASA1 Gene Capillary Malformation-Arteriovenous Malformation (CM-AVM) Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RASA1 gene. These mutations are known to cause Capillary Malformation-Arteriovenous Malformation, a rare genetic disorder characterized by the presence of capillary malformations and arteriovenous malformations in the skin, which can lead to significant medical complications. This test is crucial for individuals with a family history of CM-AVM or those exhibiting symptoms, as it provides definitive genetic evidence of the condition, enabling targeted management and treatment strategies. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variations associated with this condition.
